Efficacy and safety of tildrakizumab 100 mg for plaque psoriasis in patients randomized to treatment continuation vs treatment withdrawal with retreatment upon relapse in reSURFACE 1
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Journal of the European Academy of Dermatology and Venereology - 35(2021), 8, Seite e526-e528 |
| Beteiligte Personen: |
Cantrell, W. [VerfasserIn] |
|---|
| BKL: |
|---|
| Anmerkungen: |
Journal of the European Academy of Dermatology and Venereology © 2021 European Academy of Dermatology and Venereology |
|---|
| Umfang: |
3 |
|---|
| doi: |
10.1111/jdv.17124 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
WLY008322449 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | WLY008322449 | ||
| 003 | DE-627 | ||
| 005 | 20230307175757.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230217s2021 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1111/jdv.17124 |2 doi | |
| 028 | 5 | 2 | |a JDV_JDV17124.xml |
| 035 | |a (DE-627)WLY008322449 | ||
| 035 | |a (WILEY)JDV17124 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 082 | 0 | 4 | |a 610 |q ASE |
| 084 | |a 44.93 |2 bkl | ||
| 100 | 1 | |a Cantrell, W. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Efficacy and safety of tildrakizumab 100 mg for plaque psoriasis in patients randomized to treatment continuation vs treatment withdrawal with retreatment upon relapse in reSURFACE 1 |
| 264 | 1 | |c 2021 | |
| 300 | |a 3 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Journal of the European Academy of Dermatology and Venereology © 2021 European Academy of Dermatology and Venereology | ||
| 700 | 1 | |a Lee, P. |4 aut | |
| 700 | 1 | |a Mendelsohn, A.M. |4 aut | |
| 700 | 1 | |a Rozzo, S.J. |4 aut | |
| 700 | 1 | |a Liao, W. |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the European Academy of Dermatology and Venereology |g 35(2021), 8, Seite e526-e528 |w (DE-627)WLY008303126 |x 14683083 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2021 |g number:8 |g pages:e526-e528 |g extent:3 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_WLY | ||
| 936 | b | k | |a 44.93 |q ASE |
| 951 | |a AR | ||
| 952 | |d 35 |j 2021 |e 8 |h e526-e528 |g 3 | ||